191 related articles for article (PubMed ID: 38291338)
41. Specific T regulatory cells display broad suppressive functions against experimental allergic encephalomyelitis upon activation with cognate antigen.
Yu P; Gregg RK; Bell JJ; Ellis JS; Divekar R; Lee HH; Jain R; Waldner H; Hardaway JC; Collins M; Kuchroo VK; Zaghouani H
J Immunol; 2005 Jun; 174(11):6772-80. PubMed ID: 15905518
[TBL] [Abstract][Full Text] [Related]
42. Deleted in lymphocytic leukemia 2 induces retinoic acid receptor beta promoter methylation and mitogen activated kinase-like protein activation to enhance viability and mobility of colorectal cancer cells.
Fu L; Shi Z; Chen B
Bioengineered; 2022 May; 13(5):12847-12862. PubMed ID: 35611845
[TBL] [Abstract][Full Text] [Related]
43. PDCD5 negatively regulates autoimmunity by upregulating FOXP3(+) regulatory T cells and suppressing Th17 and Th1 responses.
Xiao J; Liu C; Li G; Peng S; Hu J; Qu L; Lv P; Zhang Y; Ma D; Chen Y
J Autoimmun; 2013 Dec; 47():34-44. PubMed ID: 24012345
[TBL] [Abstract][Full Text] [Related]
44. IL-9-triggered lncRNA Gm13568 regulates Notch1 in astrocytes through interaction with CBP/P300: contribute to the pathogenesis of experimental autoimmune encephalomyelitis.
Liu X; Zhou F; Wang W; Chen G; Zhang Q; Lv R; Zhao Z; Li X; Yu Q; Meves JM; Hua H; Li X; Wang X; Sun H; Gao D
J Neuroinflammation; 2021 May; 18(1):108. PubMed ID: 33971906
[TBL] [Abstract][Full Text] [Related]
45. Role of SMAD and non-SMAD signals in the development of Th17 and regulatory T cells.
Lu L; Wang J; Zhang F; Chai Y; Brand D; Wang X; Horwitz DA; Shi W; Zheng SG
J Immunol; 2010 Apr; 184(8):4295-306. PubMed ID: 20304828
[TBL] [Abstract][Full Text] [Related]
46. Modification of the FoxP3 transcription factor principally affects inducible T regulatory cells in a model of experimental autoimmune encephalomyelitis.
Verhagen J; Burton BR; Britton GJ; Shepard ER; Anderton SM; Wraith DC
PLoS One; 2013; 8(4):e61334. PubMed ID: 23593464
[TBL] [Abstract][Full Text] [Related]
47. microRNA-92a promotes CNS autoimmunity by modulating the regulatory and inflammatory T cell balance.
Fujiwara M; Raheja R; Garo LP; Ajay AK; Kadowaki-Saga R; Karandikar SH; Gabriely G; Krishnan R; Beynon V; Paul A; Patel A; Saxena S; Hu D; Healy BC; Chitnis T; Gandhi R; Weiner HL; Murugaiyan G
J Clin Invest; 2022 May; 132(10):. PubMed ID: 35298438
[TBL] [Abstract][Full Text] [Related]
48. Time-resolved transcriptome and proteome landscape of human regulatory T cell (Treg) differentiation reveals novel regulators of FOXP3.
Schmidt A; Marabita F; Kiani NA; Gross CC; Johansson HJ; Éliás S; Rautio S; Eriksson M; Fernandes SJ; Silberberg G; Ullah U; Bhatia U; Lähdesmäki H; Lehtiö J; Gomez-Cabrero D; Wiendl H; Lahesmaa R; Tegnér J
BMC Biol; 2018 May; 16(1):47. PubMed ID: 29730990
[TBL] [Abstract][Full Text] [Related]
49. E2F transcription factor 2-activated DLEU2 contributes to prostate tumorigenesis by upregulating serum and glucocorticoid-induced protein kinase 1.
Li P; Xu H; Yang L; Zhan M; Shi Y; Zhang C; Gao D; Gu M; Chen Y; Wang Z
Cell Death Dis; 2022 Jan; 13(1):77. PubMed ID: 35075115
[TBL] [Abstract][Full Text] [Related]
50. S3I-201, a selective stat3 inhibitor, ameliorates clinical symptoms in a mouse model of experimental autoimmune encephalomyelitis through the regulation of multiple intracellular signalling in Th1, Th17, and treg cells.
Ahmad SF; Ansari MA; Nadeem A; Bakheet SA; Al-Mazroua HA; Alomar HA; Al-Hamamah MA; Attia SM
Mult Scler Relat Disord; 2023 May; 73():104658. PubMed ID: 36989705
[TBL] [Abstract][Full Text] [Related]
51. Long noncoding RNA DLEU2 promotes growth and invasion of hepatocellular carcinoma by regulating miR-30a-5p/PTP4A1 axis.
Fu Y; Li B; Huang R; Ji X; Bai WK
Pathol Res Pract; 2022 Oct; 238():154078. PubMed ID: 36049439
[TBL] [Abstract][Full Text] [Related]
52. A GMCSF-Neuroantigen Tolerogenic Vaccine Elicits Systemic Lymphocytosis of CD4
Moorman CD; Curtis AD; Bastian AG; Elliott SE; Mannie MD
Front Immunol; 2018; 9():3119. PubMed ID: 30687323
[TBL] [Abstract][Full Text] [Related]
53. In Vivo Induction of Regulatory T Cells Via CTLA-4 Signaling Peptide to Control Autoimmune Encephalomyelitis and Prevent Disease Relapse.
Kim GR; Kim WJ; Lim S; Lee HG; Koo JH; Nam KH; Kim SM; Park SD; Choi JM
Adv Sci (Weinh); 2021 Jul; 8(14):2004973. PubMed ID: 34306974
[TBL] [Abstract][Full Text] [Related]
54. Transient Depletion of Foxp3
Watts D; Janßen M; Jaykar M; Palmucci F; Weigelt M; Petzold C; Hommel A; Sparwasser T; Bonifacio E; Kretschmer K
Front Immunol; 2021; 12():720133. PubMed ID: 34447385
[TBL] [Abstract][Full Text] [Related]
55. Dysregulated follicular regulatory T cells and antibody responses exacerbate experimental autoimmune encephalomyelitis.
Luo L; Hu X; Dixon ML; Pope BJ; Leavenworth JD; Raman C; Meador WR; Leavenworth JW
J Neuroinflammation; 2021 Jan; 18(1):27. PubMed ID: 33468194
[TBL] [Abstract][Full Text] [Related]
56. Loss of β-arrestin 2 exacerbates experimental autoimmune encephalomyelitis with reduced number of Foxp3+ CD4+ regulatory T cells.
Zhang Y; Liu C; Wei B; Pei G
Immunology; 2013 Dec; 140(4):430-40. PubMed ID: 23859136
[TBL] [Abstract][Full Text] [Related]
57. LncRNA DLEU2 silencing impedes the migration, invasion and EMT in gastric cancer cell by suppressing PI3K/AKT signaling pathway.
Hu J; Wang M; Yang Y; Xing Y; Li S
Immunopharmacol Immunotoxicol; 2022 Oct; 44(5):719-731. PubMed ID: 35736813
[No Abstract] [Full Text] [Related]
58. Inactivation of T cell receptor peptide-specific CD4 regulatory T cells induces chronic experimental autoimmune encephalomyelitis (EAE).
Kumar V; Stellrecht K; Sercarz E
J Exp Med; 1996 Nov; 184(5):1609-17. PubMed ID: 8920851
[TBL] [Abstract][Full Text] [Related]
59. Increased Th17 and regulatory T cell responses in EBV-induced gene 3-deficient mice lead to marginally enhanced development of autoimmune encephalomyelitis.
Liu JQ; Liu Z; Zhang X; Shi Y; Talebian F; Carl JW; Yu C; Shi FD; Whitacre CC; Trgovcich J; Bai XF
J Immunol; 2012 Apr; 188(7):3099-106. PubMed ID: 22387555
[TBL] [Abstract][Full Text] [Related]
60. Emerging role of long noncoding RNA-encoded micropeptides in cancer.
Ye M; Zhang J; Wei M; Liu B; Dong K
Cancer Cell Int; 2020; 20():506. PubMed ID: 33088214
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
